Clinical Trials & Research

The links below provide additional research and clinical trials information about CyberKnife and stereotactic radiosurgery.

Presentations & Papers

To view abstracts of clinical research papers co-authored by our physicians, click the buttons below.

Prospective Evaluation of CyberKnife as Monotherapy or Boost Stereotactic Body Radiotherapy for Intermediate of High Risk Localized Prostate Cancer: An Observational Study

Arica Hirsch, M.D., James Ruffer, M.D., Mjid Mohiuddin, M.D.,

Prospective Evaluation of Low-Dose Irinotecan and CyberKnife Stereotactic Body Radiotherapy in the Treatment of Patients with Colorectal Cancer and Limited Liver Metastasis

Arica Hirsch, M.D., James Ruffer, M.D., Patrick Sweeney, M.D., Majid Mohiuddin, M.D., Jacob Bitran, M.D., Anthony Simon

Stereotactic Body Radiotherapy as Monotherapy or Post–external Beam Radiotherapy Boost for Prostate Cancer: Technique, Early Toxicity, and PSA Response

Siavash Jabbari, M.D., Vivian K.Weinberg, PH.D., Tania Kaprealian, M.D., I-Chow Hsu, M.D., Lijun Ma, PH.D., Cynthia Chuang, PH.D., Martina Descovich, PH.D., Stephen Shiao, M.D., PH.D., Katsuto Shinohara, M.D., Mack Roach, III, M.D., and Alexander R. Gottschalk, M.D.,PH.D.

You can also click here to view clinical info and case studies from Accuray (the CyberKnife manufacturer) in a new browser window.

Speak with one of our dedicated nurses about how we can help today.